| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |